Glycerol phenylbutyrate regulatory update

FDA granted Fast Track designation for Hyperion's glycerol phenylbutyrate (HPN-100) as adjunctive therapy for the chronic management of urea cycle disorders (UCD). The pre-prodrug of phenylacetic acid...